Pereira Lab
@cellreprolab.bsky.social
Cell Reprogramming in Hematopoiesis and Immunity, Lund University, Sweden. Tweets by Filipe Pereira (signed FP) and Malavika Nair (for Pereira lab). https://pereiralab.com/
1/3 It’s an honor to share that our lab was awarded a Discovery grant from the American Brain Tumor Association (ABTA) for the project “In vivo Dendritic Cell Reprogramming as a New Immunotherapy for Glioblastoma”. @theabta.bsky.social
October 29, 2025 at 11:14 AM
1/3 It’s an honor to share that our lab was awarded a Discovery grant from the American Brain Tumor Association (ABTA) for the project “In vivo Dendritic Cell Reprogramming as a New Immunotherapy for Glioblastoma”. @theabta.bsky.social
1/4 Great to share that our lab was awarded a research grant from the Mats Paulsson Foundation for Research, Innovation and Societal Development for the project “Advancing Reactive Tumor-Infiltrating Lymphocyte Therapy with Cellular Reprogramming”.
October 24, 2025 at 2:47 PM
1/4 Great to share that our lab was awarded a research grant from the Mats Paulsson Foundation for Research, Innovation and Societal Development for the project “Advancing Reactive Tumor-Infiltrating Lymphocyte Therapy with Cellular Reprogramming”.
1/2 Sharing exciting news! ✨
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
October 14, 2025 at 3:41 PM
1/2 Sharing exciting news! ✨
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity!
@cp-immunity.bsky.social
1/3 Congrats to our team member @Peng Wei, who was awarded a SciLifeLab PULSE Postdoctoral Fellowship for his project SMARD, which will develop small molecule (SM)-assisted reprogramming to type 1 conventional dendritic cells (cDC1)!
For more info see: pereiralab.com/lab-news/pen...
For more info see: pereiralab.com/lab-news/pen...
Peng Wei Awarded a SciLifeLab PULSE Postdoctoral Fellowship - Pereira Lab
The researcher Peng Wei from Pereira Lab was awarded a SciLifeLab PULSE Postdoctoral Fellowship for the project SMARD—Small Molecule-Assisted Cell Reprogramming to cDC1. The SciLifeLab PULSE is a comp...
pereiralab.com
September 24, 2025 at 12:40 PM
1/3 Congrats to our team member @Peng Wei, who was awarded a SciLifeLab PULSE Postdoctoral Fellowship for his project SMARD, which will develop small molecule (SM)-assisted reprogramming to type 1 conventional dendritic cells (cDC1)!
For more info see: pereiralab.com/lab-news/pen...
For more info see: pereiralab.com/lab-news/pen...
1/2 Celebrating a double win!✨ Yesterday, at the Lund Stem Cell Center (LSCC) retreat, Ervin Ascic was awarded the Article of the Year Award with our Science paper "In vivo dendritic cell reprogramming for cancer immunotherapy" (www.science.org/doi/10.1126/...)
September 17, 2025 at 1:06 PM
1/2 Celebrating a double win!✨ Yesterday, at the Lund Stem Cell Center (LSCC) retreat, Ervin Ascic was awarded the Article of the Year Award with our Science paper "In vivo dendritic cell reprogramming for cancer immunotherapy" (www.science.org/doi/10.1126/...)
1/3 Call for Authors!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
September 8, 2025 at 11:08 AM
1/3 Call for Authors!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!
We are proud to announce that Ervin Ascic successfully defended his PhD yesterday – with the special honor of Nobel Laureate James Allison as opponent! ✨
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
September 5, 2025 at 8:29 AM
We are proud to announce that Ervin Ascic successfully defended his PhD yesterday – with the special honor of Nobel Laureate James Allison as opponent! ✨
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.
📢 New in @ImmunityCP: We have mapped the transcription factor “routes” that program two dendritic cell subsets opening paths for personalized #cancer #immunotherapy. Read it here: doi.org/10.1016/j.im...
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
August 29, 2025 at 4:11 PM
📢 New in @ImmunityCP: We have mapped the transcription factor “routes” that program two dendritic cell subsets opening paths for personalized #cancer #immunotherapy. Read it here: doi.org/10.1016/j.im...
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
Here is a summary of what we discovered 🧵:
Illustration by @azuravesta.bsky.social
1/6 Congrats to Margarida Brás and Daniel Oliveira that were awarded with PhD studentships from the Foundation for Science and Technology (FCT).
August 18, 2025 at 8:49 AM
1/6 Congrats to Margarida Brás and Daniel Oliveira that were awarded with PhD studentships from the Foundation for Science and Technology (FCT).
1/3 Our most recent protocol paper, “Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells”, is out in JoVE! @JoVEJournal
August 11, 2025 at 2:02 PM
1/3 Our most recent protocol paper, “Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells”, is out in JoVE! @JoVEJournal
Doubly proud! 🎉
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
August 3, 2025 at 1:53 PM
Doubly proud! 🎉
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
@inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.
1/3 Glad to share that the work of our Postdoctoral Fellow Sandhya Malla @mal71056 secured funding from the Hanseatic Life Science Research Infrastructure Consortium (HALRIC) to study the mechanisms of dendritic cell reprogramming!
August 3, 2025 at 1:53 PM
1/3 Glad to share that the work of our Postdoctoral Fellow Sandhya Malla @mal71056 secured funding from the Hanseatic Life Science Research Infrastructure Consortium (HALRIC) to study the mechanisms of dendritic cell reprogramming!
1/3 Congrats to our team member Hugo Couto Moreira, who was awarded a Doctoral INPhINIT Retaining Fellowship from “la Caixa” Foundation to develop his PhD project “Reprogramming Regulatory T-cells”! @FundlaCaixa
August 3, 2025 at 1:52 PM
1/3 Congrats to our team member Hugo Couto Moreira, who was awarded a Doctoral INPhINIT Retaining Fellowship from “la Caixa” Foundation to develop his PhD project “Reprogramming Regulatory T-cells”! @FundlaCaixa
It’s an honor to share that our lab was awarded a Clinic & Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI) for the project “Engineering Synthetic Tertiary Lymphoid Structures in Melanoma with Dendritic Cell Reprogramming”. @CancerResearch
August 3, 2025 at 1:52 PM
It’s an honor to share that our lab was awarded a Clinic & Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI) for the project “Engineering Synthetic Tertiary Lymphoid Structures in Melanoma with Dendritic Cell Reprogramming”. @CancerResearch
1/2 The interview series "Reprogramming Stars" featured in Cellular Reprogramming, highlights the work of leaders in the field by introducing them and their science in exciting talks. @CellRepJrnl
August 3, 2025 at 1:52 PM
1/2 The interview series "Reprogramming Stars" featured in Cellular Reprogramming, highlights the work of leaders in the field by introducing them and their science in exciting talks. @CellRepJrnl
1/2 Congrats to our PhD student @ervin_ascic for winning the best poster award in “Improving Immunity” at the 22nd #CIMT Annual Meeting, Europe's Cancer Immunotherapy Meeting, held this year in Mainz, Germany. His work was regarded as an interesting, state-of-the-art technology.
August 3, 2025 at 1:51 PM
1/2 Congrats to our PhD student @ervin_ascic for winning the best poster award in “Improving Immunity” at the 22nd #CIMT Annual Meeting, Europe's Cancer Immunotherapy Meeting, held this year in Mainz, Germany. His work was regarded as an interesting, state-of-the-art technology.
1/3 We are excited to announce that the project Repro-TIL, standing for “Breakthrough Neoantigen-specific Tumor-Infiltrating Lymphocyte Therapies Through Novel Dendritic Cell Reprogramming”, was awarded a EIC Transition grant! @EUeic
August 3, 2025 at 1:51 PM
1/3 We are excited to announce that the project Repro-TIL, standing for “Breakthrough Neoantigen-specific Tumor-Infiltrating Lymphocyte Therapies Through Novel Dendritic Cell Reprogramming”, was awarded a EIC Transition grant! @EUeic
I am excited to share that I will presenting the latest advances in in vivo reprogramming for cancer immunotherapy at the Science Spotlight session during the #ISSCR2025 Annual Meeting in Hong Kong, June 11-14, 2025.
August 3, 2025 at 1:51 PM
I am excited to share that I will presenting the latest advances in in vivo reprogramming for cancer immunotherapy at the Science Spotlight session during the #ISSCR2025 Annual Meeting in Hong Kong, June 11-14, 2025.
1/4 Celebrating our collaborative efforts, highlighted in the paper “RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen presenting cells”, recently published in @PNASNews.
August 3, 2025 at 1:51 PM
1/4 Celebrating our collaborative efforts, highlighted in the paper “RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen presenting cells”, recently published in @PNASNews.
We recently had a great get-together joining the Pereira Lab and @AsgardThx, in an Interaction Day where all members shared their paths and aspirations.
What a magnificent way to share a day with our teammates! ✨
What a magnificent way to share a day with our teammates! ✨
August 3, 2025 at 1:51 PM
We recently had a great get-together joining the Pereira Lab and @AsgardThx, in an Interaction Day where all members shared their paths and aspirations.
What a magnificent way to share a day with our teammates! ✨
What a magnificent way to share a day with our teammates! ✨
1/3 Congrats to our team member Camille Chatelain who was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship. Her project will advance a strategy for cancer therapy with tumor-reactive T cells! @MSCActions
August 3, 2025 at 1:50 PM
1/3 Congrats to our team member Camille Chatelain who was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship. Her project will advance a strategy for cancer therapy with tumor-reactive T cells! @MSCActions
1/2 I am proud to announce that I will join the SciLifeLab community as a Group Leader! @scilifelab is a health and environmental infrastructure that fosters a solid web of researchers collaborating within sectors such as industry and health care.
Read 👇
Read 👇
August 3, 2025 at 1:50 PM
1/2 I am proud to announce that I will join the SciLifeLab community as a Group Leader! @scilifelab is a health and environmental infrastructure that fosters a solid web of researchers collaborating within sectors such as industry and health care.
Read 👇
Read 👇
🌟Amazing full day of great discussions, 1-year progress updates & future planning as our @Eueic pathfinder #RESYNC consortium gathered in Turin. Exciting innovations ahead as we push the boundaries of chemical reprogramming!
#HorizonEurope
Read more:
#HorizonEurope
Read more:
August 3, 2025 at 1:50 PM
🌟Amazing full day of great discussions, 1-year progress updates & future planning as our @Eueic pathfinder #RESYNC consortium gathered in Turin. Exciting innovations ahead as we push the boundaries of chemical reprogramming!
#HorizonEurope
Read more:
#HorizonEurope
Read more:
1/3💡If you are looking for a postdoc position in transformative translational research, join our team! We are looking for a motivated postdoc to work on RNA-mediated in vivo reprogramming of cancer cells into dendritic cells.
August 3, 2025 at 1:49 PM
1/3💡If you are looking for a postdoc position in transformative translational research, join our team! We are looking for a motivated postdoc to work on RNA-mediated in vivo reprogramming of cancer cells into dendritic cells.
Excited to welcome our new postdocs to the lab! 🎉 Looking forward to exciting science, collaborations, and discoveries together.
Camille Chatelain, Peng Wei, Sandhya Malla (@mal71056), Inês Lopes (@inesrlopes13) and Sandra Schwarz.
Welcome aboard! 🚀
Camille Chatelain, Peng Wei, Sandhya Malla (@mal71056), Inês Lopes (@inesrlopes13) and Sandra Schwarz.
Welcome aboard! 🚀
August 3, 2025 at 1:49 PM
Excited to welcome our new postdocs to the lab! 🎉 Looking forward to exciting science, collaborations, and discoveries together.
Camille Chatelain, Peng Wei, Sandhya Malla (@mal71056), Inês Lopes (@inesrlopes13) and Sandra Schwarz.
Welcome aboard! 🚀
Camille Chatelain, Peng Wei, Sandhya Malla (@mal71056), Inês Lopes (@inesrlopes13) and Sandra Schwarz.
Welcome aboard! 🚀